These effects indicate that inhibition of sEH activity effectively alleviates cognitive decline in AD, suggesting that some liver products may regulate amyloid pathology and cerebrovascular damage in AD through the circulatory system or neural pathways [209]. The gene discussed is EPHX2; the disease is Alzheimer disease.